Quantcast

Posts related to ‘CRIS’

BioWatch: Curis Gets Further on Cancer Map (CRIS)

Curis Inc. (NASDAQ: CRIS) is not exactly a household name, even when it comes to the land of biotech investors.  The company has come under focus today after announcing that ...
Read Full Story »

BioHealth Business Daily (AMGN, SNY, AFFX, CORT, CRIS, CYTR, HGSI, NEXMD, NYMX, XNPT)

Today's version of the BioHealth Business Daily is a very unusual lot of movers.  Some moves are merely in sympathy and some are on news.  We also have a re-review ...
Read Full Story »

Top Day Trader Alerts (BP, CRIS, FDX, NBIX, NOK, SMTS, SONC, URRE)

There are many stocks on the move this morning in the top day trader alerts and top active trader alerts.  BP plc (NYSE: BP), Curis Inc. (NASDAQ: CRIS), FedEx Corporation ...
Read Full Story »

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks.  The American Association for Cancer Research Meeting will actually have a 100th annual ...
Read Full Story »

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are down $0.29 to $1.14. The 52 week range ...
Read Full Story »